The Armed Forces Blood Transfusion Centre (CTSA) in Paris has received Velico's first veliPod, a containerized spray dried plasma manufacturing system.
The veliPod is a modular production facility housing Velico's FrontlineODP spray dried plasma manufacturing system, enabling on-site production of spray dried plasma. This allows the French Military to establish a sovereign, large scale production of spray dried plasma, independent of traditional centralized manufacturing and cold chain constraints.
Built on a standard shipping container platform, the veliPod is engineered for rapid deployment into existing infrastructure, including military bases and blood centers. The system supports scalable production while being adaptable to regional requirements and operational environments.
"The veliPod requires only water and electricity, allowing production in a clean mobile environment without the need for heavy infrastructure such as clean rooms," said Chief Medical Officer Dr Jean-Jacques Lataillade, director of the CTSA
Uncontrolled hemorrhage remains one of the leading causes of preventable death in trauma patients worldwide. Spray dried plasma represents a potential transformative advancement in addressing this challenge.
Velico's FrontlineODP system converts liquid plasma into a stable powder that can be stored at ambient temperatures and rapidly rehydrated in under 2.5 minutes for transfusion.
Unlike conventional plasma, which requires strict cold chain management, spray dried plasma eliminates logistical barriers, significantly expanding access in remote, military, and emergency settings.
By combining speed, mobility, and technological efficiency, the veliPod aims to achieve a key operational objective: large-volume production. "The veliPod can produce up to 9,000 units per year," said Dr. Lataillade.
